Boston Trust Walden’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SIMG
CAM
MMC
AT
WCM
MMA
Boston Trust Walden's HALO Position: Q2 2026 in Review
Boston Trust Walden increased its Halozyme (HALO) stake by 59% in Q2 2026, buying an estimated $27.5M and bringing the position to 1,083,062 shares worth $84.8M. The position accounts for 0.65% of the portfolio, ranked #47.
Boston Trust Walden first reported a position in HALO in Q2 2024 and has held it in 9 quarters since. 236 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Boston Trust Walden held 1,083,062 shares of Halozyme worth $84.8M as of Q2 2026.
- Boston Trust Walden bought 403,499 Halozyme shares in Q2 2026, an estimated $27.5M.
- Halozyme made up 0.65% of Boston Trust Walden's portfolio in Q2 2026, its #47 holding.
- Boston Trust Walden first reported a position in Halozyme in Q2 2024 and has held it in 9 quarters since.
- 236 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.